Screening for esophageal varices: Endoscopy, other tools, or endoscopy and other tools?

Hepatology

Volumn 47, Issue 5, 2008, Pages 1434-1436

  Lebrec, Didier ^a,b,c   Thabut, Dominique ^b,c   Moreau, Richard ^a,b  

^a BEAUJON HOSPITAL   (France)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CAPSULE ENDOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; EDITORIAL; ESOPHAGUS VARICES; GASTROINTESTINAL ENDOSCOPY; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SCREENING TEST; THROMBOCYTE COUNT; DIAGNOSTIC TEST ACCURACY STUDY; ENDOSCOPY; GOLD STANDARD; LIGATION; PORTAL HYPERTENSION; SCREENING;

CAPSULES; ENDOSCOPY; ESOPHAGEAL AND GASTRIC VARICES; HUMANS; MASS SCREENING; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 43949144995     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22315     Document Type: Editorial

References (20)

1. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. HEPATOLOGY 2004;40:652-659.
2. Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Pagliaro L, et al. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med 1991:324:1532-1538.
3. Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. HEPATOLOGY 2001;33:802-807.
4. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167-176.
5. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic teview of 118 studies. J Hepatol 2006;44:217-231.
6. Lebrec D, de Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980;79:1139-1144.
7. Cottone M, D'Amico G, Maringhini A, Amuso M, Sciarrino E, Traina M, et al. Predictive value of ultrasonography in the screening of non-ascitic cirrhotic patients with large varices. J Ultrasound Med 1986;5:189-192.
8. Giannini EG, Zaman A, Kreil A, Floreani A, Dulbecco P, Testa E, et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol 2006;101:2511-2519.
9. Schepis F, Camma C, Niceforo D, Magnano A, Pallio S, Cinquegrani M, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? HEPATOLOGY 2001;33:333-338.
10. Thomopoulos KC, Labropoulou-Karatza C, Mimidis KP, Katsakoulis EC, Iconomou G, Nikolopoulou VN. Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis. Dig Liver Dis 2003;35:473-478.
11. Qamar AA, Grace ND, Groszmann RJ, Garcia-Tsao G, Bosch J, Burroughs AK, et al. Platelet count is not a predictor of the presence or development og gastroesophageal varices in cirrhosis. HEPATOLOGY 2008;47:153-159.
12. Riggio O, Angeloni S, Nicolini G, Merli M, Merkel C. Endoscopic screening for esophageal varices in cirrhotic patients. HEPATOLOGY 2002;35:501-502.
13. Thabut D, Trabut JB, Massard J, Rudler M, Muntenau M, Messous D, et al. Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study. Liver Im 2006;26:271-278.
14. Kazemi F, Kettaneh A, N'Kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006;45:230-235.
15. Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-telated cirrhosis. HEPATOLOGY 2007;45:1290-1297.
16. de Franchis R, Eisen GM, Laine L, Fernandez-Urien I, Herrerias JM, Brown RD, et al. Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. HEPATOLOGY 2008; doi: 10.1002/hep.22227.
17. Perri R, Chiorean MV, Fidler JL, Fletcher JG, Talwalkar JA, Stadheim L, et al. A prospective evaluation of computerized tomographic scanning as a screening modality for esophageal varices. HEPATOLOGY 2008;doi: 10.1002/hep.22219.
18. Eisen GM, Eliakim R, Zaman A, Schwartz J, Faigel D, Rondonotti E, et al. The accuracy of PillCam ESO capsule endoscopy versus conventional upper endoscopy for the diagnosis of esophageal varices: a prospective three-center pilot study. Endoscopy 2006;38:31-35.
19. Cales P, Oberti F, Bernard-Chabert B, Payen JL. Evaluation of Baveno recommendations for grading esophageal varices. J Hepatol 2003;39:657-659.
20. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-350.